Medical & Orthopedic RecoveryPowered by HealixAI • HSA/FSA Eligible

FDA-Cleared OTC Rechargeable Digital Hearing Aids

FDA-Cleared Over-the-Counter (OTC) Digital Directional Hearing Aids (HCPCS V5261) with background noise cancellation and portable charging case.

Clinically Reviewed by HealixAI Board-Certified Physicians•Neurology & Cognitive Health Formulary•HCPCS / Code: V5261
HealixAIPowered by HealixAI • Physician-Formulated
HSA / FSA Eligible • Save ~30%
FDA-Cleared OTC Rechargeable Digital Hearing Aids (Mild-to-Moderate Presbycusis)Enlarge1/3 Views
Enlarge Studio View
HealixAI Audiology DME Network

FDA-Cleared OTC Rechargeable Digital Hearing Aids (Mild-to-Moderate Presbycusis)

Chart Indication: H90.3 (Sensorineural hearing loss, bilateral)

AAO-HNS Adult Sensorineural Hearing Loss & Lancet Dementia Prevention Commission — Early amplification for mild-to-moderate bilateral sensorineural hearing loss (presbycusis — HCPCS V5261) improves speech-in-noise discrimination and reduces cognitive isolation.

$249.00$349.00~$174.30 w/ HSA·FSA
In Stock • Direct Dispatch via HealixAI Audiology DME Network
Compare stores:
Qualifying Health Goals (HSA/FSA)
  • Sensorineural hearing loss, bilateral
  • Presbycusis, unspecified ear
Clinical Guidance & Safety

AAO-HNS Adult Sensorineural Hearing Loss & Lancet Dementia Prevention Commission — Early amplification for mild-to-moderate bilateral sensorineural hearing loss (presbycusis — HCPCS V5261) improves speech-in-noise discrimination and reduces cognitive isolation.

Medication check recommended if taking: sudden unilateral hearing loss, active ear drainage / otitis externa.
Want dosing & safety tailored to your lab results and medications?

Sync your health records or ask Healix Medical Intelligence by voice on this page.